Lower-middle income (World Bank) vs Namibia: Confirmed cases of MDR-TB started treatment for MDR-TB
Lower-middle income (World Bank)
85.0%
in 2012
Namibia
100.0%
in 2012
Lower-middle income (World Bank) rank
3rd
Namibia rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Lower-middle income (World Bank)
- Namibia
How they compare
Namibia currently reports 100.0% against 85.0% in Lower-middle income (World Bank), a difference of 15.0%.
That makes Namibia's figure about 1.2 times Lower-middle income (World Bank)'s.
Across all 5 years both countries report, Namibia has been ahead every year.
Lower-middle income (World Bank) ranks 3rd and Namibia ranks 3rd of 10 groups.
Namibia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.5% | 98.5% | 47.0% | Namibia |
| 2010s | 81.7% | 100.0% | 18.3% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Lower-middle income (World Bank) or Namibia?
- Namibia, at 100.0% against 85.0% in Lower-middle income (World Bank) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Lower-middle income (World Bank) and Namibia?
- 15.0%, with Namibia ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Namibia?
- 5 years are reported by both, from 2008 to 2012.
- How do Lower-middle income (World Bank) and Namibia rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Lower-middle income (World Bank) ranks 3rd and Namibia ranks 3rd of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.